Please assess the completion status of the following clinical trial:

Trial Title: Multiple Treatment Study Using Low Field Magnetic Stimulation for Bipolar Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects will be men or women between the ages of 21-65.~2. Subjects must not have serious physical illnesses, neurological diseases or dementias.~3. Subjects will meet DSM-IV criteria for Bipolar Disorder Type I or II and meet criteria for current depression (DSM-IV major depressive episode, current).~4. Subject must have a MADRS \>= 20, Young Mania Rating Score (YMRS score) \< 7.~5. Subjects must be capable of providing informed consent.~6. Subjects must have an established residence and phone.~7. Subjects may be medicated or unmedicated.~Exclusion Criteria:~1. Dangerous or active suicidal ideation.~2. Pregnant or planning on becoming pregnant.~3. Substance abuse (cannot meet DSM criteria for substance abuse, no significant drug abuse within last 3 months, no major polysubstance abuse history, no history of dependence in last year, no drug use within last month).~4. Mania, hypomania or mixed mood state.~5. Significant medical or neurological illness that might pose a risk to study enrollment or interfere with interpretation of study data.~6. Changes in psychiatric medication (e.g. dose or drug) within 6 weeks prior to enrollment.~7. History of schizophrenia, schizoaffective, obsessive-compulsive or post-traumatic stress disorders.~8. Treatment resistant depression (as determined by the study psychiatrist; consistently and substantially symptomatic over several years despite electroconvulsive therapy, 2 or more adequate trials of a primary mood stabilizer with antidepressant effects (e.g., lithium, valproate or lamotrigine) or antidepressant medications (e.g., bupropion, Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI).)~9. Contraindications for Magnetic Resonance Imaging (MRI): Presence of a pacemaker, neurostimulator, or metal in head or neck.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- LFMS - active treatment (Type: EXPERIMENTAL): Low Field Magnetic Stimulation (LFMS) active treatment~Active low field magnetic stimulation treatment applied with the LFMS Device; the device is on and magnetic field stimulation is present.
- LFMS - sham treatment (Type: SHAM_COMPARATOR): Low Field Magnetic Stimulation - sham treatment~Inactive low field magnetic stimulation (no stimulation) treatment applied with the LFMS Device; the device is on, however no magnetic field stimulation is present.

Based on this trial design, predict the completion outcome and termination type (if applicable).